Recent Updates
Recently added Catalysts
AXGN

AxoGen, Inc. to Participate at the 28th Annual ROTH Growth Conference

Key Takeaway: ALACHUA, Fla., March 9, 2016 (GLOBE NEWSWIRE) -- via PRWEB - AxoGen, Inc. (NASDAQ: AXGN), a leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announced that Karen Zaderej, President and Chief Executive Officer, is scheduled to present

Full Press Release Details

ALACHUA, Fla., March 9, 2016 (GLOBE NEWSWIRE) -- via PRWEB - AxoGen, Inc. (NASDAQ: AXGN), a leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announced that Karen Zaderej, President and Chief Executive Officer, is scheduled to present at the 28th Annual ROTH Conference on Monday, March 14, 2016 at 4:30pm PT (7:30pm ET) in Dana Point, California.
A live webcast and subsequent archived replay of the Company's presentation may be accessed via the investor relations section of the Company's website.
Peter J. Mariani, Chief Financial Officer
InvestorRelations(at)AxoGenInc(dot)com
Michael Polyviou/Doug Sherk - Investor Relations
212.850.6020/415.652.9100
mpolyviou(at)evcgroup.com; dsherk(at)evcgroup(dot)com
This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://www.prweb.com/releases/2016/03/prweb13254085.htm

Related Links

Contact Data

Michael Polyviou/Doug Sherk - Investor Relations

Contact

With a Reader Account, it's easy to send email directly to the contact for this release. Sign up today for your free Reader Account!
Already have an account? Log in here.
Last updated: Mar 9, 2016